1. Luo, Xingguang, Lin, Xiandong, Ide, Jaime S, Tan, Yunlong, Li, Chiang-Shan R. 2023. Male-specific, replicable and functional roles of genetic variants and cerebral gray matter volumes in ADHD: a gene-wide association study across KTN1 and a region-wide functional validation across brain. In Child and adolescent psychiatry and mental health, 17, 4. doi:10.1186/s13034-022-00536-0. https://pubmed.ncbi.nlm.nih.gov/36609385/
2. Pan, Jian, Chao, Nai-Xia, Zhang, Yao-Yao, Huang, Rong-Shi, Luo, Guo-Rong. 2021. Upregulating KTN1 promotes Hepatocellular Carcinoma progression. In Journal of Cancer, 12, 4791-4809. doi:10.7150/jca.55570. https://pubmed.ncbi.nlm.nih.gov/34234850/
3. Chen, Liying, Lu, Juntao, Xu, Tongxin, Dong, Zhiming, Guo, Wei. 2022. KTN1-AS1, a SOX2-mediated lncRNA, activates epithelial-mesenchymal transition process in esophageal squamous cell carcinoma. In Scientific reports, 12, 20186. doi:10.1038/s41598-022-24743-z. https://pubmed.ncbi.nlm.nih.gov/36418920/
4. Mao, Qiao, Lin, Xiandong, Yin, Qin, Lin, Jie, Luo, Xingguang. 2023. A significant, functional and replicable risk KTN1 variant block for schizophrenia. In Scientific reports, 13, 3890. doi:10.1038/s41598-023-27448-z. https://pubmed.ncbi.nlm.nih.gov/36890161/
5. Mao, Qiao, Wang, Xiaoping, Chen, Bin, Li, Chiang-Shan R, Luo, Xingguang. 2020. KTN1 Variants Underlying Putamen Gray Matter Volumes and Parkinson's Disease. In Frontiers in neuroscience, 14, 651. doi:10.3389/fnins.2020.00651. https://pubmed.ncbi.nlm.nih.gov/32655362/
6. Gao, Lin, Chen, Shanze, Hong, Malin, Gao, Xiang, Zou, Chang. 2021. Kinectin 1 promotes the growth of triple-negative breast cancer via directly co-activating NF-kappaB/p65 and enhancing its transcriptional activity. In Signal transduction and targeted therapy, 6, 250. doi:10.1038/s41392-021-00652-x. https://pubmed.ncbi.nlm.nih.gov/34219129/
智鼠故事 
